Cancer-scanning device detects residual cancer cells post-surgery--biotech's future
Despite a surgeon's best efforts, residual cancer cells often remain after a tumor is removed. Now, a technology from NSF-funded small business NovaScan detects cancer cells in living tissue in real-time. The cancer-scanning device has already been used to find breast cancer cells. NovaScan's William Gregory talked about how the wand works at the 2014 BIO International Convention.
Provided by the National Science Foundation